KING OF PRUSSIA, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) ("Vertex” or the "Company”), a leading global provider of indirect tax solutions, today announced financial results ...

Jayne Juvan and Dan McClain of Tucker Ellis LLP discuss the slowdown in M&A transactions, in light of the rollout of tariffs, and ways to bridge the gap through contingent consideration where some of ...

Kronos Bio said it has agreed to be acquired by Concentra Biosciences at 57 cents per share and contingent rights for proceeds from sales of its product candidates.

Following a review process conducted with the assistance of its legal and financial advisors, the Kronos Bio Board of ...

Novartis has signed an agreement to acquire US-based Regulus Therapeutics and its oligonucleotide, farabursen.